{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T16:36:02Z","timestamp":1710520562356},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the conventional cholecystokinin analog, sincalide. The HBS findings analyzed included the GBEF, small bowel transit time, gallbladder fill time, and reversal of the normal gallbladder versus small bowel transit. The secondary objectives were to determine whether patient outcomes were significantly different for EP and sincalide HBS study patients following cholecystectomy, namely, the surgical pathology and patient-reported biliary-type pain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We reviewed all HBS examinations over a retrospective 34-month period. Data from 446 patients who underwent sincalide or EP HBS with GBEF determination for evaluation of chronic symptoms concerning for biliary etiology met the inclusion criteria. The aforementioned HBS findings and postsurgical patient outcomes were obtained for each patient group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Comparing HBS examinations performed with sincalide or EP, no significant differences were noted in the major HBS findings of similar patient populations. Outcomes for the sincalide and EP groups status post cholecystectomy were assessed to determine their sensitivity, specificity, positive predictive value, and negative predictive value. The outcomes assessed were the histopathology and patient-reported amelioration of biliary-type pain. No significant differences were noted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The sincalide and EP cholecystagogues did not lead to significantly different HBS findings for similar patient populations or postcholecystectomy outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002831","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:25:43Z","timestamp":1574900743000},"page":"1-6","source":"Crossref","is-referenced-by-count":2,"title":["Utilizing the Cholecystagogue, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide"],"prefix":"10.1097","volume":"45","author":[{"given":"Justin G.","family":"Peacock","sequence":"first","affiliation":[{"name":"Department of Radiology, San Antonio Military Medical Center, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared M.","family":"Katchen","sequence":"additional","affiliation":[{"name":"Department of Radiology, San Antonio Military Medical Center, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad T.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Radiology, San Antonio Military Medical Center, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.semnuclmed.2005.12.001","article-title":"Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease","volume":"36","year":"2006","journal-title":"Semin Nucl Med"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/RLU.0000000000002242","article-title":"Scintigraphic findings beyond ejection fraction on hepatobiliary scintigraphy","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib4-20230928","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2967\/jnumed.113.131490","article-title":"Hepatobiliary scintigraphy in 2014","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib5-20230928","first-page":"835","article-title":"Reproducibility of gallbladder emptying scintigraphic studies","volume":"35","year":"1994","journal-title":"J Nucl Med"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.28.2.137","article-title":"Gall bladder emptying in normal subjects\u2014a data base for clinical cholescintigraphy","volume":"28","year":"1987","journal-title":"Gut"},{"key":"bib7-20230928","first-page":"1263","article-title":"Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement","volume":"44","year":"2003","journal-title":"J Nucl Med"},{"key":"bib9-20230928","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2967\/jnmt.110.082289","article-title":"SNM practice guideline for hepatobiliary scintigraphy 4.0","volume":"38","year":"2010","journal-title":"J Nucl Med Technol"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00003072-199402000-00001","article-title":"A reversed sequence of gallbladder and small bowel visualization during cholescintigraphy. Its relationship to chronic cholecystitis","volume":"19","year":"1994","journal-title":"Clin Nucl Med"},{"key":"bib11-20230928","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2214\/ajr.140.2.283","article-title":"A sign of symptomatic chronic cholecystitis on biliary scintigraphy","volume":"140","year":"1983","journal-title":"Am J Roentgenol"},{"key":"bib12-20230928","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RLU.0b013e3181d18ef5","article-title":"Hepatobiliary scan findings in chronic cholecystitis","volume":"35","year":"2010","journal-title":"Clin Nucl Med"},{"key":"bib13-20230928","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/00003072-199210000-00002","article-title":"Comparison of gallbladder ejection fraction with histopathologic changes in acalculous biliary disease","volume":"17","year":"1992","journal-title":"Clin Nucl Med"},{"key":"bib14-20230928","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/radiology.176.2.2367674","article-title":"Delayed biliary-to-bowel transit in cholescintigraphy after cholecystokinin treatment","volume":"176","year":"1990","journal-title":"Radiology"},{"key":"bib15-20230928","first-page":"346","article-title":"Extended application of 99mTc-mebrofenin cholescintigraphy with cholecystokinin in the evaluation of abdominal pain of hepatobiliary and gastrointestinal origin","volume":"31","year":"2010","journal-title":"Nucl Med Commun Wolters Kluwer Heal Nucl Med Commun"},{"key":"bib16-20230928","first-page":"17","article-title":"Applied hepatobiliary scintigraphy in chronic gallbladder diseases","volume":"45","year":"2016","journal-title":"Appl Radiol"},{"key":"bib18-20230928","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cgh.2011.02.013","article-title":"Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib19-20230928","first-page":"694","article-title":"Quantitative gallbladder imaging following cholecystokinin","volume":"21","year":"1980","journal-title":"J Nucl Med"},{"key":"bib20-20230928","first-page":"1695","article-title":"Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease","volume":"32","year":"1991","journal-title":"J Nucl Med"},{"key":"bib21-20230928","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0016-5085(91)90540-2","article-title":"Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy","volume":"101","year":"1991","journal-title":"Gastroenterology"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:45:39Z","timestamp":1695872739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002831","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}